Design, Synthesis, Characterization, Enzyme Inhibition, Molecular Docking, and Pharmacological Evaluation of New Chalcone-Sulfonate Derivatives Bearing Thiophene

Basit Öğe Kaydı
dc.authoridkorkmaz, adem/0000-0002-0345-5794
dc.authoridASLAN, Hakan/0000-0002-5268-7196
dc.contributor.authorAslan, Hakan
dc.contributor.authorYetissin, Fuat
dc.contributor.authorKorkmaz, Adem
dc.contributor.authorBursal, Ercan
dc.date.accessioned2025-03-23T19:47:05Z
dc.date.available2025-03-23T19:47:05Z
dc.date.issued2024
dc.departmentSinop Üniversitesi
dc.description.abstractThe novel chalcone-sulfonate derivatives bearing thiophene motif were synthesized and characterized using 1H NMR, 13C NMR, and HRMS analysis. The evaluation of in vitro and in silico potential pancreatic lipase inhibition activity of the novel chalcone-sulfonate derivatives bearing thiophene motif was scanned. IC50 values of compounds 5 i (28.76 +/- 2.11 mu M) and 5 f (30.58 +/- 0.45 mu M) were determined to be more effective pancreatic lipase inhibitors for in vitro studies. The best potential inhibitor for pancreatic lipase binding affinity was found as compound 5 f (-9.8 kcal mol-1) for in silico studies. Although compounds 5 f and 5 i were identified as the best pancreatic lipase inhibitor candidates in vitro and molecular docking studies, compounds 5 f and 5 i were predicted mutagenic and carcinogenic properties in mice according to ADMET studies. Deeply, compound 5 h was a more effective pancreatic lipase inhibitor according to enzyme inhibition, molecular docking, and ADMET studies. It can be said that compound 5 h may be a more efficient drug candidate than orlistat in the treatment of obesity. This study gives a comprehensive account of the synthesis and assessment of newly developed chalcone-sulfonate derivatives bearing thiophene, specifically providing on their ability to target pancreatic lipase. In summary, our research highlights the potential of chalcone-sulfonate derivatives bearing thiophene as effective enzyme inhibitors that hold promise for therapeutic applications. image
dc.identifier.doi10.1002/slct.202400053
dc.identifier.issn2365-6549
dc.identifier.issue14
dc.identifier.scopus2-s2.0-85189917539
dc.identifier.scopusqualityQ3
dc.identifier.urihttps://doi.org/10.1002/slct.202400053
dc.identifier.urihttps://hdl.handle.net/11486/7278
dc.identifier.volume9
dc.identifier.wosWOS:001198920900001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherWiley-V C H Verlag Gmbh
dc.relation.ispartofChemistryselect
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250323
dc.subjectPancreatic lipase
dc.subjectEnzyme inhibition
dc.subjectThiophene
dc.subjectChalcone
dc.subjectand Sulfonate derivatives
dc.titleDesign, Synthesis, Characterization, Enzyme Inhibition, Molecular Docking, and Pharmacological Evaluation of New Chalcone-Sulfonate Derivatives Bearing Thiophene
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu